QuickView for myoblast fate determination (biogroup)

1. L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
2. Embryonic kidney 293T cells with methyl CpG binding-TET1 catalytic domain fusion overexpression
3. L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
4. Vastus lateralis muscles from male and female subjects after exercise
5. L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations

1. Wnt/β-catenin signaling changes C2C12 myoblast proliferation and differentiation by inducing Id3 exp…

There were no clinical trials for myoblast fate determination